|
FORSCHUNGSBERICHT 1999-2001 | INDEX
|
 Pharmazeutisches Institut Haus Poppelsdorf
 Pharmazeutisches Institut Pharmazeutische Technologie Endenich
|  Forschungsbericht
Mathematisch-Naturwissenschaftliche Fakultät
|
Allgemeine Angaben:
An der Immenburg 4, 53121 Bonn
Telefon: 0228 / 73-5212
Fax: 0228 / 73-7929
eMail: pharm.end@uni-bonn.de
WWW: http://www.pharma.uni-bonn.de/pharma/CHEMEND/index.htm
Aboul-Enein M N, El-Azzouny A, Maklad Y A, Attia M I, Wiese M
Synthesis, Selective Aldose Reductase Inhibitory Profile and Antihyperglycaemic Potential of Certain Parabenic Acid Derivatives
Sci. Pharm. 69, 329-350 (2001)
Andrade Cetto, A., Wiedenfeld, H.
Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats
J.Ethnopharmacol. 78, 145 (2001)
Andrade Cetto, A., Wiedenfeld, H., Revilla, Chr., Islas, S.
Hypoglycemic effect of Equisetum myriochaetum aerial parts on streptozotocin diabetic rats
J. Ethnopharmacol. 72, 129 (2000)
Braun K, Rettinger J, Ganso M, Kassack M, Hildebrandt C, Ullmann H, Nickel P, Schmalzing G, Lambrecht G
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors
Naunyn Schmiedebergs Arch Pharmacol. 2001; 364(3):285-90
Clemens F, Drutkowski G, Wiese M, Frohberg P
The inactivation of lipoxygenase-1 from soybeans by amidrazones
Biochim. Biophys. Acta 1549, 88-98 (2001)
Fleischer R, Frohberg P, Büge A, Nuhn P, Wiese M
QSAR analysis of substituted 2-phenylhydrazonoacetamides acting as inhibitors of 15-lipoxygenase
Quant. Struct.-Act. Relat. 19, 162-172 (2000)
Kassack MU
G-protein coupled receptor kinases and their inhibitors
Exp Op Ther Patents. 2000; 10(6):917-28
Kassack MU, Högger P, Gschwend DA, Kameyama K, Haga T, Graul RC, Sadée W
Molecular Modeling of G-protein Coupled Receptor Kinase 2: Docking and Biochemical Evaluation of Inhibitors
AAPS Pharmsci. 2000; 2(1): E2 (http://www.pharmsci.org/).
Klinger M, Freissmuth M, Nickel P, Stabler-Schwarzbart M, Kassack M, Suko J, Hohenegger M
Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site
Mol Pharmacol. 1999; 55(3):462-472
Pajeva I K, Wiese M
Human P-Glycoprotein Pseudoreceptor Modeling: 3D-QSAR Study on Thioxanthene Type Multidrug Resistance Modulators
Quant. Struct.-Act. Relat. 20, 130-138 (2001)
Peinhardt G, Wiese M
Microionization constants: novel approach for the determination of the zwitterionic equilibrium of hydroxyphenylalkylamines by photometric titration
Int. J. Pharm. 215, 83-89 (2001)
Röder, E., Wiedenfeld, H., Edgar, J.
Linolensäurehaltige Öle aus Boraginaceen
Dtsch. Apoth. Ztg. 141, 554 (2001)
Schop H, Wiese M, Cordes H-P, Seydel JK
Partialresistance of E. coli mutants against 2,4-diamino-5-benzylpyrimidines by interactions with bacterial membrane lipopolysaccharides. Derivation of quantitative structure-binding relationships
Eur. J. Med. Chem. 35, 619-634 (2000)
Weigt M, Wiese M
A comparative molecular field analysis of inhibitors of tubulin polymerization
Struct.-Act. Relat. 19, 142-148 (2000)
Wiedenfeld, H., Andrade Cetto, A.
Pyrrolizidine Alkaloids from Ageratum houstonianum Mill.
Phytochemistry 57, 1269 (2001)
Wiedenfeld, H., Andrade Cetto, A., Perez-Amador, Chr.
Flavonol glycosides from Equisetum myriochaetum
Biochem. Syst. Ecol. 28, 395 (1999)
Wiedenfeld, H., Narantuya, S., Altanchimeg, D., Röder, E.
Pyrrolizidine Alkaloids in Senecio nemorensis from Mongolia
Sci. Pharm. 68, 207 (2000)
Wiese M, Pajeva I K
Structure-Activity Relationships of Multidrug Resistance Reversers
Curr. Med. Chem. 8, 685-713 (2001)
| eMail: Transfer und Öffentlichkeitsarbeit |
|